Poly (adp -核糖)聚合酶-1酶在多种实体犬肿瘤中过表达:免疫组织化学研究

IF 2.3 2区 农林科学 Q1 VETERINARY SCIENCES
Veterinary and comparative oncology Pub Date : 2025-06-01 Epub Date: 2025-04-03 DOI:10.1111/vco.13053
Shana De Vos, Simone Janssen, Sophie Favril, Hilde De Cock, Matthijs Vynck, Jonas Steenbrugge, Ward De Spiegelaere, Hilde de Rooster
{"title":"Poly (adp -核糖)聚合酶-1酶在多种实体犬肿瘤中过表达:免疫组织化学研究","authors":"Shana De Vos, Simone Janssen, Sophie Favril, Hilde De Cock, Matthijs Vynck, Jonas Steenbrugge, Ward De Spiegelaere, Hilde de Rooster","doi":"10.1111/vco.13053","DOIUrl":null,"url":null,"abstract":"<p><p>The enzyme poly (ADP-ribose) polymerase-1 (PARP-1) is crucial for cellular regulation and DNA repair. Its immunohistochemical overexpression is known in various human neoplasms, but it was not yet a topic of veterinary research. Formalin-fixed paraffin-embedded canine samples of 15 controls and 34 tumours were immunohistochemically tested for PARP-1 expression. Controls included five skin samples with mast cells, five oral mucosa samples and five thyroid glands. Tumours included 18 mast cell tumours (MCTs), 10 oral squamous cell carcinomas (SCCs) and six follicular thyroid carcinomas. A board-certified veterinary pathologist defined the optimal region for the blind PARP-1 evaluation, assessed by two independent veterinary PhD students. Positive nuclei were evaluated by the immunoreactivity score (IRS) and quick score (QS) and, for both scores, the averages of the two observers were used for statistical analysis. In all MCTs, 6/10 SCCs and all thyroid carcinomas as well as four thyroid controls a nuclear expression was observed. A cytoplasmic granular staining was visible in all dermal mast cells and in 11/18 MCTs due to non-specific antibody uptake. No PARP-1 was expressed in 11/15 controls.Compared to the controls, thyroid carcinomas significantly overexpressed PARP-1 when calculated by IRS and QS (p = 0.003 and p = 0.005, respectively). The latter also applied to the MCTs (p = 0.001). A significantly higher PARP-1 IRS and QS were observed in thyroid carcinomas (p = 0.003, p = 0.005) and MCTs (p = 0.003, p = 0.012) compared to oral SCCs. The immunohistochemical PARP-1 overexpression in these tumours invites further research to assess its potential as a therapeutic target.</p>","PeriodicalId":23693,"journal":{"name":"Veterinary and comparative oncology","volume":" ","pages":"267-277"},"PeriodicalIF":2.3000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Poly (ADP-Ribose) Polymerase-1 Enzyme Is Overexpressed in Various Solid Canine Tumours: An Immunohistochemical Study.\",\"authors\":\"Shana De Vos, Simone Janssen, Sophie Favril, Hilde De Cock, Matthijs Vynck, Jonas Steenbrugge, Ward De Spiegelaere, Hilde de Rooster\",\"doi\":\"10.1111/vco.13053\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The enzyme poly (ADP-ribose) polymerase-1 (PARP-1) is crucial for cellular regulation and DNA repair. Its immunohistochemical overexpression is known in various human neoplasms, but it was not yet a topic of veterinary research. Formalin-fixed paraffin-embedded canine samples of 15 controls and 34 tumours were immunohistochemically tested for PARP-1 expression. Controls included five skin samples with mast cells, five oral mucosa samples and five thyroid glands. Tumours included 18 mast cell tumours (MCTs), 10 oral squamous cell carcinomas (SCCs) and six follicular thyroid carcinomas. A board-certified veterinary pathologist defined the optimal region for the blind PARP-1 evaluation, assessed by two independent veterinary PhD students. Positive nuclei were evaluated by the immunoreactivity score (IRS) and quick score (QS) and, for both scores, the averages of the two observers were used for statistical analysis. In all MCTs, 6/10 SCCs and all thyroid carcinomas as well as four thyroid controls a nuclear expression was observed. A cytoplasmic granular staining was visible in all dermal mast cells and in 11/18 MCTs due to non-specific antibody uptake. No PARP-1 was expressed in 11/15 controls.Compared to the controls, thyroid carcinomas significantly overexpressed PARP-1 when calculated by IRS and QS (p = 0.003 and p = 0.005, respectively). The latter also applied to the MCTs (p = 0.001). A significantly higher PARP-1 IRS and QS were observed in thyroid carcinomas (p = 0.003, p = 0.005) and MCTs (p = 0.003, p = 0.012) compared to oral SCCs. The immunohistochemical PARP-1 overexpression in these tumours invites further research to assess its potential as a therapeutic target.</p>\",\"PeriodicalId\":23693,\"journal\":{\"name\":\"Veterinary and comparative oncology\",\"volume\":\" \",\"pages\":\"267-277\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Veterinary and comparative oncology\",\"FirstCategoryId\":\"97\",\"ListUrlMain\":\"https://doi.org/10.1111/vco.13053\",\"RegionNum\":2,\"RegionCategory\":\"农林科学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2025/4/3 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"VETERINARY SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Veterinary and comparative oncology","FirstCategoryId":"97","ListUrlMain":"https://doi.org/10.1111/vco.13053","RegionNum":2,"RegionCategory":"农林科学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/4/3 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"VETERINARY SCIENCES","Score":null,"Total":0}
引用次数: 0

摘要

聚(adp -核糖)聚合酶1 (PARP-1)在细胞调节和DNA修复中起着至关重要的作用。它的免疫组织化学过表达在各种人类肿瘤中是已知的,但尚未成为兽医研究的主题。采用免疫组织化学方法检测15例对照和34例肿瘤犬标本中PARP-1的表达。对照组包括5个带有肥大细胞的皮肤样本,5个口腔粘膜样本和5个甲状腺样本。肿瘤包括18例肥大细胞瘤(mct), 10例口腔鳞状细胞癌(SCCs)和6例甲状腺滤泡癌。一位委员会认证的兽医病理学家确定了PARP-1盲评估的最佳区域,由两名独立的兽医博士生进行评估。采用免疫反应性评分(IRS)和快速评分(QS)评价阳性细胞核,两项评分均取两名观察者的平均值进行统计分析。在所有mct、6/10 SCCs和所有甲状腺癌以及4例甲状腺对照中,均观察到核表达。由于非特异性抗体摄取,在所有真皮肥大细胞和11/18 mct中可见细胞质颗粒染色。11/15对照组未表达PARP-1。与对照组相比,经IRS和QS计算,甲状腺癌患者PARP-1显著过表达(p = 0.003和p = 0.005)。后者也适用于mct (p = 0.001)。甲状腺癌(p = 0.003, p = 0.005)和mct (p = 0.003, p = 0.012)中PARP-1 IRS和QS均显著高于口服SCCs。免疫组织化学PARP-1在这些肿瘤中的过表达需要进一步的研究来评估其作为治疗靶点的潜力。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
The Poly (ADP-Ribose) Polymerase-1 Enzyme Is Overexpressed in Various Solid Canine Tumours: An Immunohistochemical Study.

The enzyme poly (ADP-ribose) polymerase-1 (PARP-1) is crucial for cellular regulation and DNA repair. Its immunohistochemical overexpression is known in various human neoplasms, but it was not yet a topic of veterinary research. Formalin-fixed paraffin-embedded canine samples of 15 controls and 34 tumours were immunohistochemically tested for PARP-1 expression. Controls included five skin samples with mast cells, five oral mucosa samples and five thyroid glands. Tumours included 18 mast cell tumours (MCTs), 10 oral squamous cell carcinomas (SCCs) and six follicular thyroid carcinomas. A board-certified veterinary pathologist defined the optimal region for the blind PARP-1 evaluation, assessed by two independent veterinary PhD students. Positive nuclei were evaluated by the immunoreactivity score (IRS) and quick score (QS) and, for both scores, the averages of the two observers were used for statistical analysis. In all MCTs, 6/10 SCCs and all thyroid carcinomas as well as four thyroid controls a nuclear expression was observed. A cytoplasmic granular staining was visible in all dermal mast cells and in 11/18 MCTs due to non-specific antibody uptake. No PARP-1 was expressed in 11/15 controls.Compared to the controls, thyroid carcinomas significantly overexpressed PARP-1 when calculated by IRS and QS (p = 0.003 and p = 0.005, respectively). The latter also applied to the MCTs (p = 0.001). A significantly higher PARP-1 IRS and QS were observed in thyroid carcinomas (p = 0.003, p = 0.005) and MCTs (p = 0.003, p = 0.012) compared to oral SCCs. The immunohistochemical PARP-1 overexpression in these tumours invites further research to assess its potential as a therapeutic target.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Veterinary and comparative oncology
Veterinary and comparative oncology 农林科学-兽医学
CiteScore
4.80
自引率
9.50%
发文量
75
审稿时长
>24 weeks
期刊介绍: Veterinary and Comparative Oncology (VCO) is an international, peer-reviewed journal integrating clinical and scientific information from a variety of related disciplines and from worldwide sources for all veterinary oncologists and cancer researchers concerned with aetiology, diagnosis and clinical course of cancer in domestic animals and its prevention. With the ultimate aim of diminishing suffering from cancer, the journal supports the transfer of knowledge in all aspects of veterinary oncology, from the application of new laboratory technology to cancer prevention, early detection, diagnosis and therapy. In addition to original articles, the journal publishes solicited editorials, review articles, commentary, correspondence and abstracts from the published literature. Accordingly, studies describing laboratory work performed exclusively in purpose-bred domestic animals (e.g. dogs, cats, horses) will not be considered.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信